|
|
 News |
News about the Misgav Venture Accelerator
24/4/2013 Misgav newsletter Q2 2013
2/5/2013 VP New Ventures mentioned in Hebrew press
23/1/2013 Misgav newsletter Q1 2013
24/7/2012 Misgav newsletter Q3 2012
24/10/2012 Misgav Newsletter Q4 2012
8/1/2012 Misgav Venture Accelerator featured in Israel21c
10/6/2012 URINFO, a product from FlowSense, featured in Israel 21C
1/2/2012 Misgav newsletter Q1 2012
1/5/2012 Misgav newsletter Q2 2012
22/4/2012 Minnesota students to visit Misgav
12/12/2011 Misgav Newsletter Q4 2011
15/7/2011 Misgav Newsletter Q3 2011 (July 2011)
24/5/2011 Misgav featured in Jerusalem Post article on ILSI BioMed
2/5/2011 Misgav Newsletter Q2 2011
31/1/2011 Misgav Newsletter Q1 2011
19/7/2010 Misgav Named Incubator of the Year
1/7/2010 Misgav Newsletter Q2 2010
1/4/2010 Misgav Newsletter Q 1 2010
7/1/2010 Misgav Newsletter Q4 2009
5/1/2009 The Misgav Venture Accelerator Sums Up Another Successful Year
19/10/2009 Misgav newsletter Q3 2009
7/7/2009 Misgav newsletter Q2 2009
24/6/2009 Misgav Venture Accelerator at Biomed Israel 2009 -- photo gallery
21/6/2009 The incubator that put down roots in the Galilee
4/2/2009 DailyMaily interview with Steve Rhodes
24/3/2009 Misgav Newsletter Q1 2009
29/12/2008 Misgav Newsletter Q4 2008
22/10/2008 Misgav Newsletter Q3 2008
13/7/2008 Misgav Newsletter Q2 2008
13/4/2008 Misgav Newsletter Q1 2008
News about Our Portfolio Companies
8/5/2013 Israeli company has found a method to diagnose Alzheimer's disease before symptoms
16/4/2013 Encision and Virtual Ports Announce Exclusive Distribution Agreement
12/3/2013 ETView receives approval to market in China -- jumps by 26%
14/2/2013 ApiFix receives CE mark and completes successful trial
13/2/2013 Urine monitor co Flowsense in sale talks at $7-10m value
12/2/2013 Innovative Implant for Treating Adolescent Scoliosis (Hebrew)
12/2/2013 Israel’s Stimatix to Compete in $2 Billion Stoma Market
4/2/2013 Blood test for Alzheimer's from NeuroQuest
29/1/2013 Patents approved for Virtual Ports
18/12/2012 Israeli biotech company looks to open S.C. development center
29/11/2012 Headway's innovation shown to demonstrate reduction in headaches and neck pain
10/12/2012 NeuroQuest close to validation trial for biomarker platform in diagnosis of Alzheimer's
16/5/2011 FDA accepts Dune Medical's PMA application
5/11/2012 Immunovative CEO interviewed on Big Biz Show
31/10/2012 Bee Surgical, Endobetix raise NIS 5m through Misgav incubator
15/8/2012 MitrAssist featured in Medtech Insight
2/10/2012 Dune Medical and VacciGuard featured in Israel21c
6/9/2012 Globes Names ProArc Start-Up of the Week
26/8/2012 Inspiro featured in "A smarter inhaler for asthmatic kids"
1/5/2012 Stimatix GI appears in the media
5/8/2012 Stimatix GI Best Start-Up Award Appears in Israel 21c
22/6/2012 FDA advisory panel approves Dune's MarginProbe
7/7/2012 Inspiro named Start-Up of the Week (Hebrew)
6/6/2012 Stimatix GI Wins 2012 Best Start-Up of the Year
30/6/2011 FlowSense featured in The Marker (Hebrew)
30/4/2012 PolyTouch acquisition appears in media
15/4/2012 ApiFix featured in Israel21c
25/3/2012 Investment in Juvenis featured in media
27/3/2012 Follow us on the Trendlines U.S. Road Show
7/9/2011 Headway's raise featured in Hebrew press
5/2/2012 ETView featured in Hebrew press
4/9/2011 Organis (Bio[pack]) featured in Israel21c
16/5/2011 Dune Medical's breast cancer device featured in Mass High Tech
23/11/2011 Dune Medical's CFO appointment featured in Mass High Tech
3/1/2012 Immunovative Therapies agreement featured in Hebrew press
17/10/2011 ETView featured in Telniri (Hebrew)
8/12/2011 FlowSense cooperation with Philips featured in Hebrew press
15/12/2011 ETView featured in Medical Device Daily
2/1/2012 ET View featured in Bizportal (Hebrew)
12/1/2012 FlowSense featured in Hebrew press
4/1/2012 FlowSense agreement with Doctors Oxygen featured in Hebrew press
5/10/2011 Mofet company, Sol Chip, wins in U.S.-Israel Business Competition
15/8/2011 Juvenis Featured in Globes (in Hebrew)
8/8/2011 Johnson & Johnson invests in Lifebond
23/5/2011 Calcalist features Stimatix as one of top 10 most promising BioMed companies
1/1/2009 Trendlines portfolio company Lifebond raises $20M, featured in Globes
23/5/2011 Immunovative Therapies to go public through US reverse merger
11/4/2011 Israel 21C features Tenergel, a product developed by Juvenis
24/4/2011 ETView Medical Ltd. and Stopler Belgium Execute Distribution Agreement
1/1/2010 ETView inks a deal with CODAN AB
7/1/2010 Wound care co EnzySurge raises $4.1m
22/12/2009 EnzySurge Secures US$2.5 Million in Private Capital
15/12/2009 Wound treatment co EnzySurge gets FDA nod
15/12/2009 Successful entrepreneur helps develop R&D for HTL and Life Bond - (Heb)
25/10/2009 A new treatment for chronic wounds
11/10/2009 HTL signs with Cheisi Group (Hebrew)
7/10/2009 HTL signs agreemeent with leading Italian pharmaceutical company
24/9/2009 Infection Control Today article mentions Flexicath
29/9/2009 OMNIVISION PROVIDES DISPOSABLE CAMERAS FOR NEXT GENERATION MEDICAL INTUBATION SYSTEM
29/9/2009 Good news from the FDA for Flexicath
14/9/2009 Virtual Ports raises $2.6 million (Hebrew)
16/9/2009 Gluing together expertise to help save lives
15/9/2009 Laparoscopy co Virtual Ports raises $2.6m
15/9/2009 Scorpion Surgical Technologies appears in Biomedical Business & Technology
8/9/2009 Immunovative Therapies to raise $2m for human trials
8/9/2009 Immunovative seeks $2 million (Hebrew)
16/8/2009 Catheter co Flexicath signs $1m US cooperation deal
17/8/2009 Virtual Ports receives CE approval for laparoscopic tools (Hebrew)
16/8/2009 Laparoscopy co Virtual Ports gets EU CE Mark
16/8/2009 CryoStim cancer treatment to begin FDA clinical trials September 1, 2009
16/7/2009 Israeli company designing innovative spine implants
30/6/2009 ID-U completes performance evaluation
23/6/2009 ETView signs distribution agreement (Hebrew)
23/6/2009 ETView signs US distribution deal
20/5/2009 Stimatix recieves Ministry of Industry, Trade & Labor approval (Hebrew)
16/6/2009 PolyTouch takes second place in Most Promising Life Science Initiative (Hebrew)
9/6/2009 Virtual Ports one of the "most promising" biomed start-ups (Hebrew)
2/6/2009 LifeBond completes $8 million funding round
7/5/2009 Virtual Ports begins official market launch
1/3/2009 Scorpion reports successful pre-clinical trial (Hebrew)
4/12/2008 Medical device co Flexicath raises $600,000
|
|
|
|
